New Jersey S 1756: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2018-02-05)

State: New Jersey · Session: 218 · Bill: S 1756

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Weinberg, Loretta

View New Jersey S 1756 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.